“Research Use Only” Peptides in Clinical Practice: Why the Label Does Not Eliminate Liability
News & Posts “Research Use Only” Peptides in Clinical Practice: Why the Label Does Not Eliminate Liability “Research Use Only” (RUO) peptides are explicitly designated
After the July 2026 FDA Peptide Meeting: What Clinics, Compounders, and Distributors Should Review Now
News & Posts After the July 2026 FDA Peptide Meeting: What Clinics, Compounders, and Distributors Should Review Now Following the July 2026 FDA peptide meeting,
A Peptide May Be Compoundable – But Is It Insurable? What Clinic Owners Need to Ask
News & Posts A Peptide May Be Compoundable—but Is It Insurable? What Clinic Owners Need to Ask The compoundability of peptides does not guarantee their
PT-141 Peptide vs Viagra and Cialis: What Clinics Need to Know Before Offering Both
News & Posts PT-141 Peptide vs Viagra and Cialis: What Clinics Need to Know Before Offering Both Clinics contemplating the simultaneous provision of PT-141 Peptide